R Campbell
Overview
Explore the profile of R Campbell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
355
Citations
4876
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Campbell R, Shaw J, Carlick T, Banks H, Faris M, Jeon M, et al.
J Cancer Surviv
. 2024 Oct;
PMID: 39405030
Purpose: Cancer-related fatigue (CRF) is one of the most common symptoms reported by people with primary brain tumour (BT). Previous research predominantly examined CRF using quantitative assessments, failing to capture...
2.
Mostof Zadeh Haghighi D, Xu J, Campbell R, Moopanar T
Musculoskelet Surg
. 2024 Oct;
PMID: 39400866
No abstract available.
3.
Robusto J, Coulthard L, Yates C, Mantha S, Campbell R
Childs Nerv Syst
. 2024 Sep;
40(12):4083-4087.
PMID: 39349774
Purpose: Pre-operative fourth ventricle roof angle (FVRA) has recently been highlighted as a novel radiographic predictor of clinical severity in Chiari type-I malformation (CM-I) as reported by Seaman et al....
4.
Mostofi Zadeh Haghighi D, Xu J, Campbell R, Moopanar T
Musculoskelet Surg
. 2024 Aug;
109(1):9-15.
PMID: 39115679
This systematic review compares Kirschner wires versus a single cannulated screw for the treatment of lateral humeral condyle fractures in children. The purpose of this review is to review the...
5.
Shiroiwa T, King M, Norman R, Muller F, Campbell R, Kemmler G, et al.
Qual Life Res
. 2024 May;
33(7):1865-1879.
PMID: 38724771
Purpose: This study aimed to develop a Japanese value set for the EORTC QLU-C10D, a multi-attribute utility measure derived from the cancer-specific health-related quality-of-life (HRQL) questionnaire, the EORTC QLQ-C30. The...
6.
Gately L, Mesia C, Sepulveda J, Del Barco S, Pineda E, Girones R, et al.
J Neurooncol
. 2024 Apr;
168(2):299-306.
PMID: 38630385
Purpose: The impact of age on optimal management of glioblastoma remains unclear. A recent combined analysis of two randomised trials, GEINO14-01 and EX-TEM, found no benefit from extending post-radiation temozolomide...
7.
Gately L, Mesia C, Sepulveda J, Del Barco S, Pineda E, Girones R, et al.
J Neurooncol
. 2024 Jan;
166(3):417-418.
PMID: 38289531
No abstract available.
8.
Gately L, Mesia C, Sepulveda J, Del Barco S, Pineda E, Girones R, et al.
J Neurooncol
. 2023 Dec;
166(3):407-415.
PMID: 38153582
Purpose: The optimal duration of post-radiation temozolomide in newly diagnosed glioblastoma remains unclear, with no published phase III randomised trials. Standard-of-care stipulates 6 months. However, in routine care, it is...
9.
Wong K, Hughes D, Debski M, Latt N, Assaf O, Abdelrahman A, et al.
Acta Cardiol
. 2023 Sep;
78(7):828-837.
PMID: 37694719
Objectives: Acute heart failure (AHF) hospitalisation is associated with 10% mortality. Outpatient based management (OPM) of AHF appeared effective in observational studies. We conducted a pilot randomised controlled trial (RCT)...
10.
Hasan M, Bath P, Marincowitz C, Sutton L, Pilbery R, Hopfgartner F, et al.
Comput Biol Med
. 2022 Nov;
151(Pt A):106024.
PMID: 36327887
Background: COVID-19 infected millions of people and increased mortality worldwide. Patients with suspected COVID-19 utilised emergency medical services (EMS) and attended emergency departments, resulting in increased pressures and waiting times....